<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31999698</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.</ArticleTitle><Pagination><StartPage>e0227655</StartPage><MedlinePgn>e0227655</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0227655</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0227655</ELocationID><Abstract><AbstractText>Mutations in Cu/Zn superoxide dismutase 1 (SOD1) associated with familial amyotrophic lateral sclerosis cause the protein to aggregate via a prion-like process in which soluble molecules are recruited to aggregates by conformational templating. These misfolded SOD1 proteins can propagate aggregation-inducing conformations across cellular membranes. Prior studies demonstrated that mutation of a Trp (W) residue at position 32 to Ser (S) suppresses the propagation of misfolded conformations between cells, whereas other studies have shown that mutation of Trp 32 to Phe (F), or Cys 111 to Ser, can act in cis to attenuate aggregation of mutant SOD1. By expressing mutant SOD1 fused with yellow fluorescent protein (YFP), we compared the relative ability of these mutations to modulate the formation of inclusions by ALS-mutant SOD1 (G93A and G85R). Only mutation of Trp 32 to Ser persistently reduced the formation of the amorphous inclusions that form in these cells, consistent with the idea that a Ser at position 32 inhibits templated propagation of aggregation prone conformations. To further test this idea, we produced aggregated fibrils of recombinant SOD1-W32S in vitro and injected them into the spinal cords of newborn mice expressing G85R-SOD1: YFP. The injected mice developed an earlier onset paralysis with a frequency similar to mice injected with WT SOD1 fibrils, generating a strain of misfolded SOD1 that produced highly fibrillar inclusion pathology. These findings suggest that the effect of Trp 32 in modulating the propagation of misfolded SOD1 conformations may be dependent upon the "strain" of the conformer that is propagating.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crown</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAlary</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry &amp; Molecular Bioscience, University of Wollongong, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, School of Chemistry &amp; Molecular Bioscience, University of Wollongong, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagerli</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Hilda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yerbury</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry &amp; Molecular Bioscience, University of Wollongong, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, School of Chemistry &amp; Molecular Bioscience, University of Wollongong, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galaleldeen</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, St. Mary's University, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashman</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borchelt</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Jacob I</ForeName><Initials>JI</Initials><Identifier Source="ORCID">0000-0003-4544-2366</Identifier><AffiliationInfo><Affiliation>Center for Translational Research in Neurodegenerative Disease, SantaFe HealthCare Alzheimer's Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Neurodegenerative Disease, University of California, San Francisco, California, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS092788</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS088839</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD020026</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31999698</ArticleId><ArticleId IdType="pmc">PMC6991973</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0227655</ArticleId><ArticleId IdType="pii">PONE-D-19-27450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362: 59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244: 6049&#x2013;6055.</Citation><ArticleIdList><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol. 1974;41: 35&#x2013;97. 10.1002/9780470122860.ch2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470122860.ch2</ArticleId><ArticleId IdType="pubmed">4371571</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. 2012;33: 1345&#x2013;1351. 10.1002/humu.22157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Hart PJJ, Borchelt DRR, Andersen PMM. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet. 2009;18: 3217&#x2013;3226. 10.1093/hmg/ddp260</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp260</ArticleId><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Knibb JA, Keren N, Kulka A, Leigh PN, Martin S, Shaw CE, et al. A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry. 2016;87: 1361&#x2013;1367. 10.1136/jnnp-2015-312908</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312908</ArticleId><ArticleId IdType="pmc">PMC5136716</ArticleId><ArticleId IdType="pubmed">27378085</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DRR, Lee MKK, Slunt HSS, Guarnieri M, Xu Z-SS, Wong PCC, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A. 1994;91: 8292&#x2013;8296. 10.1073/pnas.91.17.8292</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Canto MCD, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264: 1772&#x2013;1775. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, Marklund SL. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol. 2006;65: 1126&#x2013;1136. 10.1097/01.jnen.0000248545.36046.3c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248545.36046.3c</ArticleId><ArticleId IdType="pubmed">17146286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, Culotta VC, et al. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet. 1999;8: 1451&#x2013;1460. 10.1093/hmg/8.8.1451</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.8.1451</ArticleId><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136: 2342&#x2013;2358. 10.1093/brain/awt097</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Laing N, Hurse PV, Brown RHJ. Toxic mutants in Charcot&#x2019;s sclerosis. Nature. 1995;378: 342&#x2013;343. 10.1038/378342a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/378342a0</ArticleId><ArticleId IdType="pubmed">7477368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, Liu HN, Croul S, Bilbao J, Rogaeva E, Zinman L, et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119: 335&#x2013;344. 10.1007/s00401-010-0646-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0646-5</ArticleId><ArticleId IdType="pubmed">20111867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Sumi-Akamaru H, Fujimura H, Sakoda S, Kato M, Hirano A, et al. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Acta Neuropathol. 2001;102: 233&#x2013;238. 10.1007/s004010000355</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010000355</ArticleId><ArticleId IdType="pubmed">11585247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, Piao YS, Hayashi S, Obata H, Umeda Y, Sato M, et al. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation. Acta Neuropathol. 2004;108: 332&#x2013;336. 10.1007/s00401-004-0893-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0893-4</ArticleId><ArticleId IdType="pubmed">15235802</ArticleId></ArticleIdList></Reference><Reference><Citation>Takehisa Y, Ujike H, Ishizu H, Terada S, Haraguchi T, Tanaka Y, et al. Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and lewy body-like hyaline inclusions. Arch Neurol. 2001;58: 736&#x2013;740. 10.1001/archneur.58.5.736</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.5.736</ArticleId><ArticleId IdType="pubmed">11346368</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, Svendsen CN. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci. 2008;31: 192&#x2013;198. 10.1016/j.tins.2008.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2008.01.006</ArticleId><ArticleId IdType="pubmed">18329734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Ohsawa Y, Yamane K, Sakuma H, Shibata N, Nakano R, et al. Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions. Neurology. 1998;51: 871&#x2013;873. 10.1212/wnl.51.3.871</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.51.3.871</ArticleId><ArticleId IdType="pubmed">9748044</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw CE, Enayat ZE, Powell JF, Anderson VE, Radunovic A, al-Sarraj S, et al. Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology. 1997;49: 1612&#x2013;1616. 10.1212/wnl.49.6.1612</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.49.6.1612</ArticleId><ArticleId IdType="pubmed">9409355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubo Y, Kuzuhara S, Narita Y, Kikugawa K, Nakano R, Inuzuka T, et al. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Arch Neurol. 1999;56: 1506&#x2013;1508. 10.1001/archneur.56.12.1506</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.12.1506</ArticleId><ArticleId IdType="pubmed">10593307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabado J, Casanovas A, Hernandez S, Piedrafita L, Hereu M, Esquerda JE. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2013;72: 646&#x2013;661. 10.1097/NEN.0b013e318297fd10</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318297fd10</ArticleId><ArticleId IdType="pubmed">23771221</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Wate R, Kaneko S, Ito H, Oki M, Tsuge A, et al. An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation. Neuropathology. 2014;34: 58&#x2013;63. 10.1111/neup.12049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12049</ArticleId><ArticleId IdType="pubmed">23773010</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Berner C, Thal DR, Attems J, Ludolph AC, Otto M. Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot. Acta Neuropathol Commun. 2014;2: 130 10.1186/s40478-014-0130-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0130-x</ArticleId><ArticleId IdType="pmc">PMC4156642</ArticleId><ArticleId IdType="pubmed">25159221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hineno A, Nakamura A, Shimojima Y, Yoshida K, Oyanagai K, Ikeda S. Distinctive clinicopathological features of 2 large families with amyotrophic lateral sclerosis having L106V mutation in SOD1 gene. J Neurol Sci. 2012;319: 63&#x2013;74. 10.1016/j.jns.2012.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.05.014</ArticleId><ArticleId IdType="pubmed">22647583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohi T, Nabeshima K, Kato S, Yazawa S, Takechi S. Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions. J Neurol Sci. 2004;225: 19&#x2013;25. 10.1016/j.jns.2004.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.06.008</ArticleId><ArticleId IdType="pubmed">15465081</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Bergemalm D, Andersen PM, Gredal O, Brannstrom T, Marklund SL. Inclusions of amyotrophic lateral sclerosis-linked superoxide dismutase in ventral horns, liver, and kidney. Ann Neurol. 2008;63: 671&#x2013;675. 10.1002/ana.21356</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21356</ArticleId><ArticleId IdType="pubmed">18409196</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Hirano A, Kobayashi M, Siddique T, Deng HX, Hung WY, et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol. 1996;55: 481&#x2013;490. 10.1097/00005072-199604000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199604000-00011</ArticleId><ArticleId IdType="pubmed">8786408</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Asayama K, Hirano A, Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci. 1996;18: 492&#x2013;498. 10.1159/000111445</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000111445</ArticleId><ArticleId IdType="pubmed">8940623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, Gredal O, et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127: 73&#x2013;88. 10.1093/brain/awh005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2000;97: 12571&#x2013;12576. 10.1073/pnas.220417997</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220417997</ArticleId><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinder GA, Lacourse MC, Minotti S, Durham HD. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem. 2001;276: 12791&#x2013;12796. Available: http://www.jbc.org/cgi/content/abstract/276/16/12791
10.1074/jbc.M010759200
</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010759200</ArticleId><ArticleId IdType="pubmed">11278741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Borchelt DR. High molecular weight complexes of mutant superoxide dismutase 1: age- dependent and tissue-specific accumulation. Neurobiol Dis. 2002;9: 139&#x2013;148. 10.1006/nbdi.2001.0471</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0471</ArticleId><ArticleId IdType="pubmed">11895367</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol. 2003;10: 461&#x2013;467. 10.1038/nsb935</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb935</ArticleId><ArticleId IdType="pubmed">12754496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Slunt HHH, Gonzales V, Coonfield M, Fromholt D, et al. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis. 2005;20: 943&#x2013;952. 10.1016/j.nbd.2005.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.06.005</ArticleId><ArticleId IdType="pubmed">16046140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, et al. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128: 791&#x2013;803. 10.1007/s00401-014-1342-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sea K, Sohn SH, Durazo A, Sheng Y, Shaw BF, Cao X, et al. Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase. J Biol Chem. 2015;290: 2405&#x2013;2418. 10.1074/jbc.M114.588798</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.588798</ArticleId><ArticleId IdType="pmc">PMC4303690</ArticleId><ArticleId IdType="pubmed">25433341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13: 1396&#x2013;1403. 10.1038/nn.2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O&#x2019;Neill MA, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111: 3620&#x2013;3625. 10.1073/pnas.1312245111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoSONE. 2010;5: e11552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton TE, Li Y, Cooper D, Gearing M, Julien JP, Rothstein JD, et al. Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS. Proc Natl Acad Sci U S A. 2012;109: 5505&#x2013;5510. 10.1073/pnas.1115009109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115009109</ArticleId><ArticleId IdType="pmc">PMC3325721</ArticleId><ArticleId IdType="pubmed">22431618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Xu G, Pletnikova O, Troncoso JCC, Hart PJJ, Borchelt DRR. Conformatonal specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases. Acta Neuropathol Commun. 2014;2: 55 10.1186/2051-5960-2-55</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-55</ArticleId><ArticleId IdType="pmc">PMC4035506</ArticleId><ArticleId IdType="pubmed">24887207</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Bui A, Saberi S, Lee SK, Stauffer J, McAlonis-Downes M, et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 2017;134: 97&#x2013;111. 10.1007/s00401-017-1688-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1688-8</ArticleId><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P, Lambert-Smith IA, Bean DM, Freer R, Cid F, Tartaglia GG, et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc Natl Acad Sci U S A. 2017;114: E3935&#x2013;E3943. 10.1073/pnas.1613854114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613854114</ArticleId><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem. 2002;277: 47551&#x2013;47556. 10.1074/jbc.M207356200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207356200</ArticleId><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, O&#x2019;Halloran TV. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem. 2005;280: 17266&#x2013;17274. 10.1074/jbc.M500482200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500482200</ArticleId><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>DiDonato M, Craig L, Huff ME, Thayer MM, Cardoso RM, Kassmann CJ, et al. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol. 2003;332: 601&#x2013;615. 10.1016/s0022-2836(03)00889-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-2836(03)00889-1</ArticleId><ArticleId IdType="pubmed">12963370</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Boca M, Girotto S, Martinelli M, Valentine JS, et al. SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PLoS One. 2008;3: e1677 10.1371/journal.pone.0001677</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001677</ArticleId><ArticleId IdType="pmc">PMC2250751</ArticleId><ArticleId IdType="pubmed">18301754</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Kaneko K, Yamanaka K, Nukina N. Mutation-dependent polymorphism of Cu,Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis. J Biol Chem. 2010;285: 22221&#x2013;22231. 10.1074/jbc.M110.113597</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.113597</ArticleId><ArticleId IdType="pmc">PMC2903422</ArticleId><ArticleId IdType="pubmed">20404329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt AJ, Shin DS, Merz GE, Rambo RP, Lancaster WA, Dyer KN, et al. Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes. Proc Natl Acad Sci U S A. 2014;111: E4568&#x2013;76. 10.1073/pnas.1308531111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308531111</ArticleId><ArticleId IdType="pmc">PMC4217430</ArticleId><ArticleId IdType="pubmed">25316790</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolvahabi A, Shi Y, Rhodes NR, Cook NP, Marti AA, Shaw BF. Arresting amyloid with coulomb&#x2019;s law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation. Biophys J. 2015;108: 1199&#x2013;1212. 10.1016/j.bpj.2015.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2015.01.014</ArticleId><ArticleId IdType="pmc">PMC4375441</ArticleId><ArticleId IdType="pubmed">25762331</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Anzai I, Akiyama S, Imai M, Cruz FJ, Saio T, et al. Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis. J Biol Chem. 2016;291: 4144&#x2013;4155. 10.1074/jbc.M115.683763</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.683763</ArticleId><ArticleId IdType="pmc">PMC4759189</ArticleId><ArticleId IdType="pubmed">26694608</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolvahabi A, Shi Y, Chuprin A, Rasouli S, Shaw BF. Stochastic Formation of Fibrillar and Amorphous Superoxide Dismutase Oligomers Linked to Amyotrophic Lateral Sclerosis. ACS Chem Neurosci. 2016;7: 799&#x2013;810. 10.1021/acschemneuro.6b00048</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00048</ArticleId><ArticleId IdType="pubmed">26979728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, Whitelegge JP, et al. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci U S A. 2008;105: 18663&#x2013;18668. 10.1073/pnas.0807058105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807058105</ArticleId><ArticleId IdType="pmc">PMC2585484</ArticleId><ArticleId IdType="pubmed">19022905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Nwadibia E, Strong CD, Gralla EB, Valentine JS, Whitelegge JP. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation. J Biol Chem. 2015;290: 30624&#x2013;30636. 10.1074/jbc.M115.666503</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.666503</ArticleId><ArticleId IdType="pmc">PMC4683282</ArticleId><ArticleId IdType="pubmed">26511321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova MI, Sievers SA, Guenther EL, Johnson LM, Winkler DD, Galaleldeen A, et al. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014;111: 197&#x2013;201. 10.1073/pnas.1320786110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320786110</ArticleId><ArticleId IdType="pmc">PMC3890817</ArticleId><ArticleId IdType="pubmed">24344300</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffmo KS, Forsberg K, Bergh J, Birve A, Zetterstrom P, Andersen PM, et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22: 51&#x2013;60. 10.1093/hmg/dds399</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds399</ArticleId><ArticleId IdType="pubmed">23026746</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, Pokrishevsky E, O&#x2019;Neill MA, Gibbs E, et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108: 16398&#x2013;16403. 10.1073/pnas.1102645108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4: e1000193 10.1371/journal.pgen.1000193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniecka Z, Polymenidou M. From nucleation to widespread propagation: A prion-like concept for ALS. Virus Res. 2015;207: 94&#x2013;105. 10.1016/j.virusres.2014.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.12.032</ArticleId><ArticleId IdType="pubmed">25656065</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassall KA, Stubbs HR, Primmer HA, Tong MS, Sullivan SM, Sobering R, et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc Natl Acad Sci U S A. 2011;108: 2210&#x2013;2215. 10.1073/pnas.0913021108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913021108</ArticleId><ArticleId IdType="pmc">PMC3038722</ArticleId><ArticleId IdType="pubmed">21257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, Bertolotti A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J Mol Biol. 2010;399: 512&#x2013;525. 10.1016/j.jmb.2010.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.04.019</ArticleId><ArticleId IdType="pmc">PMC2927901</ArticleId><ArticleId IdType="pubmed">20399791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang YM, Stathopulos PB, Dimmick K, Yang H, Badiei HR, Tong MS, et al. Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis. J Biol Chem. 2010;285: 41701&#x2013;41711. 10.1074/jbc.M110.113696</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.113696</ArticleId><ArticleId IdType="pmc">PMC3009897</ArticleId><ArticleId IdType="pubmed">20974846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Tattum MH, Jones S, Collinge J, Fisher EMC, Jackson GS. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One. 2010;5: e10627 10.1371/journal.pone.0010627</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010627</ArticleId><ArticleId IdType="pmc">PMC2869360</ArticleId><ArticleId IdType="pubmed">20498711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, McMahon B, Gill S, Lelie HL, Fromholt S, Brown H, et al. Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models. J Neurochem. 2017;140: 140&#x2013;150. 10.1111/jnc.13864</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13864</ArticleId><ArticleId IdType="pmc">PMC5283795</ArticleId><ArticleId IdType="pubmed">27727458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Diamond J, Sari A, Fromholt S, Galaleldeen A, Ostrow LW, et al. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol. 2016;132: 827&#x2013;840. 10.1007/s00401-016-1623-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1623-4</ArticleId><ArticleId IdType="pmc">PMC5107152</ArticleId><ArticleId IdType="pubmed">27704280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstrom P, Andersen PM, Marklund SL, Brannstrom T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest. 2016;126: 2249&#x2013;2253. 10.1172/JCI84360</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor DM, Gibbs BF, Kabashi E, Minotti S, Durham HD, Agar JN. Tryptophan 32 potentiates aggregation and cytotoxicity of a copper/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2007;282: 16329&#x2013;16335. 10.1074/jbc.M610119200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M610119200</ArticleId><ArticleId IdType="pubmed">17389599</ArticleId></ArticleIdList></Reference><Reference><Citation>DuVal MG, Hinge VK, Snyder N, Kanyo R, Bratvold J, Pokrishevsky E, et al. Tryptophan 32 mediates SOD1 toxicity in a in vivo motor neuron model of ALS and is a promising target for small molecule therapeutics. Neurobiol Dis. 2019;124: 297&#x2013;310. 10.1016/j.nbd.2018.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.025</ArticleId><ArticleId IdType="pubmed">30528257</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, McAlary L, Farrawell NE, Zhao B, Sher M, Yerbury JJ, et al. Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci Rep. 2018;8: 15590 10.1038/s41598-018-32835-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32835-y</ArticleId><ArticleId IdType="pmc">PMC6197196</ArticleId><ArticleId IdType="pubmed">30349065</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Borchelt DR. A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem. 2008;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376231</ArticleId><ArticleId IdType="pubmed">18316367</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BLTL, Patel K, Brown HHH, Borchelt DRR. Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures. PLoS One. 2012;7: e47838 10.1371/journal.pone.0047838</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047838</ArticleId><ArticleId IdType="pmc">PMC3485248</ArticleId><ArticleId IdType="pubmed">23118898</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, Carri MT. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2008;283: 866&#x2013;874. 10.1074/jbc.M705657200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M705657200</ArticleId><ArticleId IdType="pmc">PMC2842925</ArticleId><ArticleId IdType="pubmed">18006498</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Hong RH, Mackenzie IR, Cashman NR. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS One. 2017;12: e0184384 10.1371/journal.pone.0184384</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184384</ArticleId><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990;18: 5322 10.1093/nar/18.17.5322</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/18.17.5322</ArticleId><ArticleId IdType="pmc">PMC332193</ArticleId><ArticleId IdType="pubmed">1698283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state. Proc Natl Acad Sci. 2002;99: 16607&#x2013;16612. Available: http://www.pnas.org/cgi/content/abstract/99/26/16607
10.1073/pnas.262527099
</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.262527099</ArticleId><ArticleId IdType="pmc">PMC139191</ArticleId><ArticleId IdType="pubmed">12482932</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Aquilina JA, Yerbury JJ. Susceptibility of Mutant SOD1 to Form a Destabilized Monomer Predicts Cellular Aggregation and Toxicity but Not In vitro Aggregation Propensity. Front Neurosci. 2016;10: 499 10.3389/fnins.2016.00499</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00499</ArticleId><ArticleId IdType="pmc">PMC5095133</ArticleId><ArticleId IdType="pubmed">27867347</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette PA, Whitson LJ, Cao X, Schirf V, Demeler B, Valentine JS, et al. Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability. J Biol Chem. 2004;279: 54558&#x2013;54566. 10.1074/jbc.M409744200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409744200</ArticleId><ArticleId IdType="pubmed">15485869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci U S A. 2009;106: 1392&#x2013;1397. 10.1073/pnas.0813045106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813045106</ArticleId><ArticleId IdType="pmc">PMC2631083</ArticleId><ArticleId IdType="pubmed">19171884</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls DAA, Prudencio M, Roberts BLL, Crosby K, Brown H, Borchelt DRR. Features of wild-type human SOD1 limit interactions with misfolded aggregates of mouse G86R Sod1. Mol Neurodegener. 2013;8: 46 10.1186/1750-1326-8-46</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-46</ArticleId><ArticleId IdType="pmc">PMC3881023</ArticleId><ArticleId IdType="pubmed">24341866</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls DA, Crosby K, Brown H, Borchelt DR. An analysis of interactions between fluorescently-tagged mutant and wild-type SOD1 in intracellular inclusions. PLoS One. 2013;8: e83981 10.1371/journal.pone.0083981</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083981</ArticleId><ArticleId IdType="pmc">PMC3877123</ArticleId><ArticleId IdType="pubmed">24391857</ArticleId></ArticleIdList></Reference><Reference><Citation>Crown AM, Roberts BL, Crosby K, Brown H, Ayers JI, Hart PJ, et al. Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis. G3 (Bethesda). 2019;9: 719&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404617</ArticleId><ArticleId IdType="pubmed">30622123</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Borchelt DR. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. MolNeurodegener. 2011;6: 77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248846</ArticleId><ArticleId IdType="pubmed">22094223</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Julien JP. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2007;104: 2495&#x2013;2500. 10.1073/pnas.0606201104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Auclair JR, Maniatis S, Shaffer SA, Agar J, Bosco DA. Identification of a Misfolded Region in Superoxide Dismutase 1 that is Exposed in Amyotrophic Lateral Sclerosis. J Biol Chem. 2014;289: 28257&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192504</ArticleId><ArticleId IdType="pubmed">25164820</ArticleId></ArticleIdList></Reference><Reference><Citation>Oztug Durer ZA, Cohlberg JA, Dinh P, Padua S, Ehrenclou K, Downes S, et al. Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase. PLoS One. 2009;4: e5004 10.1371/journal.pone.0005004</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005004</ArticleId><ArticleId IdType="pmc">PMC2659422</ArticleId><ArticleId IdType="pubmed">19325915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang L, Kurnik M, Danielsson J, Oliveberg M. Fibrillation precursor of superoxide dismutase 1 revealed by gradual tuning of the protein-folding equilibrium. Proc Natl Acad Sci U S A. 2012;109: 17868&#x2013;17873. 10.1073/pnas.1201795109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1201795109</ArticleId><ArticleId IdType="pmc">PMC3497812</ArticleId><ArticleId IdType="pubmed">22797895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh J, Zetterstrom P, Andersen PM, Brannstrom T, Graffmo KS, Jonsson PA, et al. Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc Natl Acad Sci U S A. 2015;112: 4489&#x2013;4494. 10.1073/pnas.1419228112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419228112</ArticleId><ArticleId IdType="pmc">PMC4394267</ArticleId><ArticleId IdType="pubmed">25802384</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho FR, Iqbal A, Linares E, Silva DF, Lima FS, Cuccovia IM, et al. Oxidation of the tryptophan 32 residue of human superoxide dismutase 1 caused by its bicarbonate-dependent peroxidase activity triggers the non-amyloid aggregation of the enzyme. J Biol Chem. 2014;289: 30690&#x2013;30701. 10.1074/jbc.M114.586370</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.586370</ArticleId><ArticleId IdType="pmc">PMC4215247</ArticleId><ArticleId IdType="pubmed">25237191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray SS, L PT Jr. A possible therapeutic target for Lou Gehrig&#x2019;s disease. Proc Natl Acad Sci U S A. 2004;101: 5701&#x2013;5702. 10.1073/pnas.0401934101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0401934101</ArticleId><ArticleId IdType="pmc">PMC395856</ArticleId><ArticleId IdType="pubmed">15079068</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S, Takahashi Y, Yamamoto K, Masutani H, Fujiwara N, Urushitani M, et al. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS. Hum Mol Genet. 2015;24: 3427&#x2013;3439. 10.1093/hmg/ddv093</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv093</ArticleId><ArticleId IdType="pubmed">25762155</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JC, Chia R, Hendriks WT, Bros-Facer V, van M J, Martin JE, et al. Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag&#x2014;implications for research into amyotrophic lateral sclerosis (ALS). PLoSONE. 2010;5: e9541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2833207</ArticleId><ArticleId IdType="pubmed">20221404</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>